bpHope.com on MSN
Bipolar research & insights: Mania genes, cannabis, and pregnancy sleep | March 2026
How 3 new studies use modern science to explore age-old questions and support people living with bipolar disorder today. Key ...
The FDA has approved Bysanti (milsaperidone) tablets for the treatment of bipolar I disorder and schizophrenia in adults. The drug is indicated as a first-line therapy for acute manic or mixed ...
Recently published Bipolar Depression Market Insights report includes a comprehensive understanding of current treatment practices, bipolar depression emerging drugs, market share of individual ...
Dr McIntyre and colleagues share new insight on how GLP-1 receptor agonists may protect against lithium-induced kidney damage in patients treated for bipolar disorder.
Imagine you're a 20 year old university student without any prior history of bipolar symptoms. Thus far, you've been on top of your game—attendance at an elite university, excellent grades, numerous ...
ROCHESTER, Minn. -- A preliminary study of 85 patients with bipolar disorder shows that a drug used to treat patients with sleep disorders might also control the depressive symptoms associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results